In the face of many obstacles, Nicaragua’s history in ensuring a national deworming program has shed light on the potential for success.  Former Global Netw

By Dr. Dagna Constenla, Director of Economics & Financing at the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health

The BRICS countries ― Brazil, Russia, India, China, and South Africa ― are a group of emerging economies distinguished by their growing influence in regional and global affairs.

Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

This week in the Global Post, Dr. Fred Were, a pediatrician and specialist in neonatal medicine and National Chairman of the Kenya Pediatric Association (KPA), wrote about the dengue outbreak that swept his country in October. Dr.

This is the second post in a blog mini-series from the Dengue Vaccine Initiative about the collaborative work being done to ensure future access to dengue vaccines in developing nations

Pages